These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6449903)

  • 41. In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.
    Levison ME; Knight R; Kaye D
    Antimicrob Agents Chemother; 1972 May; 1(5):381-4. PubMed ID: 4670478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I; Machka K; Elsser R
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.
    Casellas JM; Tomé G; Bantar C; Bertolini P; Blázquez N; Borda N; Couto E; Cudmani N; Guerrera J; Juárez MJ; López T; Littvik A; Méndez E; Notario R; Ponce G; Quinteros M; Salamone F; Sparo M; Sutich E; Vaylet S; Wolff L
    Diagn Microbiol Infect Dis; 2003 Nov; 47(3):527-37. PubMed ID: 14596972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of cefoxitin, alone and in combination with aminoglycoside or other beta-lactam antibiotics against common gram-negative pathogens.
    Markowitz SM; Sibilla DJ
    Chemotherapy; 1983; 29(2):89-98. PubMed ID: 6839865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity.
    Trager GM; White GW; Zimelis VM; Panwalker AP
    Antimicrob Agents Chemother; 1979 Sep; 16(3):297-300. PubMed ID: 315753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1980 Oct; 18(4):582-5. PubMed ID: 6255862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.
    Lewis RP; Meyer RD; Kraus LL
    Antimicrob Agents Chemother; 1976 May; 9(5):780-6. PubMed ID: 949175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL; Glenn S; DiPersio JR; Leist PA
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro comparison of mezlocillin and piperacillin plus tobramycin or gentamicin versus 100 gram-negative nosocomial bloodstream isolates.
    Cabezudo I; Pfaller MA; Barrett M; Bale M; Wenzel RP
    Am J Infect Control; 1990 Aug; 18(4):250-6. PubMed ID: 2403216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM; Moellering RC
    Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
    Chan E; Zhou S; Srikumar S; Duan W
    Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.
    Thabaut A; Durosoir JL; Saliou P
    Infection; 1982; 10 Suppl 3():S249-56. PubMed ID: 7152690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
    Briedis DJ; Robson HG
    Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.
    Pogwizd SM; Lerner SA
    Antimicrob Agents Chemother; 1976 Dec; 10(6):878-84. PubMed ID: 795373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies of in vitro synergy between several beta-lactam and aminoglycoside antibiotics against endocarditis strains of Pseudomonas aeruginosa.
    Reyes MP; Smith F; Lerner AM
    J Infect; 1984 Mar; 8(2):110-7. PubMed ID: 6725964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin.
    Tack KJ; Sabath LD
    Chemotherapy; 1985; 31(3):204-10. PubMed ID: 3888545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Piperacillin: in vitro evaluation.
    Bodey GP; Le Blanc B
    Antimicrob Agents Chemother; 1978 Jul; 14(1):78-87. PubMed ID: 28694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.